☆ 4.4 Article

Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus

ARTHRITIS CARE & RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d

Savino Sciascia et al.

Summary: High titers of aPL often remain positive, allowing for earlier diagnosis and risk assessment at the initial screening. Low titers may require retesting. There is a high correlation between aCL and aB2GP1 measured using two different technologies. The correlation between PC4d and aPL is low to moderate, suggesting a possible additional value in evaluating the association with thrombosis in autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Rheumatology

Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus

Selcan Demir et al.

Summary: The study showed that LA remained the best predictor of thrombosis in SLE patients, and adding additional aPL did not increase the risk except for anti-beta(2)-glycoprotein I IgA.

RHEUMATOLOGY (2021)

Add to Collection

Review Immunology

Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis

Xiaohong Lu et al.

Summary: The systematic review and meta-analysis found that patients with systemic lupus erythematosus (SLE) have a higher risk of developing cardiovascular disease (CVD) compared to the general or healthy population, and the risk of CVD in lupus nephritis (LN) patients is significantly higher than in SLE patients.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Immunology

Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus

Yevgeniya Gartshteyn et al.

Summary: Elevated levels of PC4d are associated with arterial events in SLE patients, independent of antiphospholipid status, smoking, and prednisone use. PC4d levels are correlated with abnormalities in platelet function and may serve as a mechanistic marker for vascular disease in SLE.

CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Rheumatology

Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving Story

Murray B. Urowitz et al.

JOURNAL OF RHEUMATOLOGY (2020)

Add to Collection

Article Rheumatology

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus

Elisabet Svenungsson et al.

RHEUMATOLOGY (2020)

Add to Collection

Article Rheumatology

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort

Murray B. Urowitz et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Add to Collection

Article Rheumatology

Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE

Michelle A. Petri et al.

LUPUS SCIENCE & MEDICINE (2019)

Add to Collection

Review Rheumatology

The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus

Ozan Unlu et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis

Flavia Ballocca et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)

Add to Collection

Article Clinical Neurology

Relation of Platelet C4d with All-Cause Mortality and Ischemic Stroke in Patients with Systemic Lupus Erythematosus

Amy H. Kao et al.

TRANSLATIONAL STROKE RESEARCH (2014)

Add to Collection

Article Rheumatology

Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus

Michelle Petri et al.

ARTHRITIS AND RHEUMATISM (2012)

Add to Collection

Article Biochemical Research Methods

pROC: an open-source package for R and S plus to analyze and compare ROC curves

Xavier Robin et al.

BMC BIOINFORMATICS (2011)

Add to Collection

Article Medicine, General & Internal

Combined oral contraceptives in women with systemic lupus erythematosus

M Petri et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Review Hematology

Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

M Galli et al.

BLOOD (2003)

Add to Collection

Article Hematology

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

M Galli et al.

BLOOD (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.